Following on from their breakthrough human trial that successfully reprogrammed the immune system to overpower glioblastoma, an aggressive brain tumor, the same scientists have now further developed ...

Iovance Biotherapeutics, Inc. stock faces challenges with disappointing Q1 earnings and competition. Click for why potential ...

The combination of RPI, a genetically engineered herpes simplex virus type 1, and Opdivo shrank both injected and non-injected tumors by 30%.

A deadly tick-borne illness, severe fever with thrombocytopenia syndrome (SFTS), continues to claim lives with no specific ...

An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers ...

In this week’s edition of The Prototype, we look at a new company building automated construction equipment, a potential new class of virus-fighting compounds and more.

Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and gene therapy.

In part 2, Hans Lee, MD, shares practical tips for using linvoseltamab in heavily pretreated multiple myeloma and outlines trials that may expand its future role.

An experimental mRNA vaccine has boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to ...

Head and neck cancer (HNC) occurred in a small but distinct subgroup of patients with dermatomyositis (DM), in a ...

Research students at McDaniel College are spending part of their summer on a multiyear project that could one day keep viruses like COVID-19 from spreading.

Research students at McDaniel College are spending part of their summer on a multiyear project that could one day keep ...